Pharma & Biotech

Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm...

Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market forecasts when it released quarterly results...

Glaukos Corporation has ignited investor enthusiasm with a powerful trifecta of developments, propelling its stock to impressive gains. The equity...

All eyes are on Vericel as the biopharmaceutical company prepares to release its quarterly financial results this Thursday. Market expectations...

Pulmonx Corp witnessed a dramatic single-day rally, with its stock price soaring more than 26% following significant corporate developments. The...

Stoke Therapeutics equity faced substantial selling pressure as new clinical trial results triggered a sharp decline in its market value....

Emergent BioSolutions shares are witnessing a remarkable transformation following unexpectedly robust quarterly earnings. The biopharmaceutical giant not only surpassed all...

The upcoming quarterly report from RxSight represents a pivotal moment for the medical technology firm. With the company scheduled to...

Syndax Pharmaceuticals finds itself navigating turbulent market conditions following a significant regulatory achievement. The biotech firm's stock has experienced substantial...

Neogen Corporation finds itself navigating turbulent waters as new leadership takes the helm and mixed quarterly results create uncertainty among...